Queensland Clinical Trials & Biostatistics Centre
News
- In collaboration with A/Prof. Sanjoy Paul of QCTBC, researchers at Peking University have found that conventional drugs were significantly more effective when used alongside traditional Chinese medicine in the treatment of type 2 diabetes, as reported in Ji et al., PLoS One 2013; 8(2): e56703 and UQ News.
- QCTBC to run 2 new NHMRC-funded large phase 3 clinical trials in the fields of critical care and geriatric medicine
- APCN-QCTBC wins UQ-CIEF grant to initiate studies in the field of Parkinson's disease
- BTCCRC-QCTBC wins RBWH Hospital Foundation grant to evaluate cardiovascular risk in burns patients
- Sanjoy Paul invited to speak at BioPharma Australasia Convention, Sydney, 23-24 August 2012
- Smart Futures Co-Investment Fund for QCTBC: The Centre (as a member of TIA-Qld Node) has received this prestigious Qld Government grant (total $2M) to conduct clinical translational research in diabetes (May, 2012)
- QCTBC Reports the First Clinical Exploratory Study on Cardio-metabolic Effects of GLP-1R Agonist, April, 2012
| Queensland Clinical Trials & Biostatistics Centre section |
|
|
|
|
QCTBC has the infrastructure & trained manpower to be able to conduct early and late phase clinical trials strictly following the regulatory guidelines (FDA) and biopharmaceutical industry standard.
|
|
QCTBC's Current Research Projects
|
|
Research opportunities for students in QCTBC
|
|
QCTBC offers high-level clinical research consulting services to both academic and corporate clients, in various fields of clinical studies.
|
|
We collaborate in clinical studies with academic and commercial organisations at all levels.
|
|
Read about our major research programmes.
|
|
A selection of our most recent publications.
|
|
The QCTBC Team
|
|
We are based at the Princess Alexandra Hospital in Brisbane, Queensland, Australia.
|
